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During mosquito transmission, malaria ookinetes must cross a chitin-containing structure known as the
peritrophic matrix (PM), which surrounds the infected blood meal in the mosquito midgut. In turn, ookinetes
produce multiple chitinase activities presumably aimed at disrupting this physical barrier to allow ookinete
invasion of the midgut epithelium. Plasmodium chitinase activities are demonstrated targets for human and
avian malaria transmission blockade with the chitinase inhibitor allosamidin. Here, we identify and charac-
terize the first chitinase gene of a rodent malaria parasite, Plasmodium berghei. We show that the gene, named
PbCHT1, is a structural ortholog of PgCHT1 of the avian malaria parasite Plasmodium gallinaceum and a
paralog of PfCHT1 of the human malaria parasite Plasmodium falciparum. Targeted disruption of PbCHT1
reduced parasite infectivity in Anopheles stephensi mosquitoes by up to 90%. Reductions in infectivity were also
observed in ookinete feeds—an artificial situation where midgut invasion occurs before PM formation—
suggesting that PbCHT1 plays a role other than PM disruption. PbCHT1 null mutants had no residual
ookinete-derived chitinase activity in vitro, suggesting that P. berghei ookinetes express only one chitinase gene.
Moreover, PbCHT1 activity appeared insensitive to allosamidin inhibition, an observation that raises ques-
tions about the use of allosamidin and components like it as potential malaria transmission-blocking drugs.
Taken together, these findings suggest a fundamental divergence among rodent, avian, and human malaria
parasite chitinases, with implications for the evolution of Plasmodium-mosquito interactions.
After ingestion of infectious Plasmodium gametocytes by the
mosquito, motile ookinetes develop in the midgut lumen and
traverse the chitin-containing peritrophic matrix (PM), the mi-
crovillus-associated network, and the midgut epithelium to
form sporozoite-producing oocysts on the hemocoel side of the
midgut (11, 18). After the demonstration that ookinetes se-
crete multiple chitinase activities (6), two distinct Plasmodium
chitinase genes were isolated. The first was isolated from the
human malaria parasite Plasmodium falciparum (PfCHT1)
(14), while the second was found in the avian malaria parasite
Plasmodium gallinaceum (PgCHT1) (15). The primary struc-
tures of these two chitinase genes are markedly different:
PgCHT1 encodes putative amino-terminal proenzyme and car-
boxy-terminal chitin-binding domains, which are both absent in
PfCHT1. P. gallinaceum secretes a second chitinase activity
provisionally named PgCHT2, believed to be orthologous to
that encoded by PfCHT1 based on its molecular mass and
physiological properties (pH optimum and sensitivity to the
chitinase inhibitor allosamidin), and it may have additional
chitinase activities (15).
The Streptomyces-produced molecule allosamidin is a 622-
dalton pseudo-oligosaccharide that inhibits Plasmodium chiti-
nase activities in vitro (10, 14, 15). Moreover, the presence of
allosamidin in an infected blood meal inhibited oocyst forma-
tion of P. gallinaceum in Aedes aegypti and of P. falciparum in
Anopheles freeborni, a process that was reversed when the PM
was prevented from forming by the addition of exogenous
chitinase to the blood meal (10). Although these inhibitor
studies identified Plasmodium chitinases as potential malaria
transmission-blocking targets, dissection of the roles of the
individual chitinase activities in mosquito infection remains a
prerequisite for a rational chitinase-based transmission-block-
ing vaccine or drug design. For this purpose, we have isolated
a chitinase gene of the rodent malaria parasite Plasmodium
berghei, a Plasmodium species amenable to such experiments
because of its suitability for obtaining stable transgenic gene
knockout parasites and its ability to form large numbers of
ookinetes in vitro for study. We show that the isolated P.
berghei chitinase gene, named PbCHT1, contains putative
proenzyme and chitin-binding domains and is a structural or-
tholog of PgCHT1. The construction of transgenic PbCHT1
null mutants has allowed us to establish that P. berghei ooki-
netes have only one apparent chitinase activity. We show that
these parasites have significantly reduced, but not abolished,
infectivity in mosquitoes. Our data further suggest that Pb-
CHT1 may play a role other than PM penetration and is
insensitive to allosamidin. The biological significance of these
findings is discussed.
MATERIALS AND METHODS
Parasite maintenance, culturing, and purification; differential screening; RNA
extraction and purification; Southern, Northern, and Western blotting; and mos-
quito infections were performed as described previously (3).
Gene isolation and sequence analysis. From the partial cDNA, the complete
PbCHT1 sequence was obtained with the gene-specific primer F02-RACE (CG
ATACCAGGTGCCCGTGTTGAATAG) using SMART rapid amplification of
cDNA ends (RACE) (Clontech Laboratories) according to the manufacturer’s
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instructions. Sequence analyses were carried out with the MacVector package
(Oxford Molecular).
Construction of transgenic parasites. A 600-bp fragment corresponding to the
59 portion of the PbCHT1 mRNA was amplified with primers CHIT-BAM
(GGATCCATTTTTTTGGAGACTTTATAACA) and CHIT-ERI (GAATTCT
AAAATTTCCCTTGGAGA), digested with BamHI and EcoRI, and ligated into
BamHI/EcoRI-digested pBS-DHFR (3) to give pCHT1-BE. A 530-bp fragment
corresponding to the 39 portion of the PbCHT1 mRNA was amplified with
primers CHIT-KPN (GGTACCAAATATATGCAATGTAACTAAAA) and
CHIT-HIND (AAGCTTAAACAATGGCATGGAGG), digested with KpnI and
HindIII, and ligated into KpnI/HindIII-digested pCHT1-BE to give the transfec-
tion plasmid pPbCHT1-KO. Fifty micrograms of pCHT1-KO was digested with
KpnI and BamHI to excise the plasmid backbone and transfected into purified
schizonts as described previously (16). Pyrimethamine selection of transformed
parasites and limiting dilution cloning were performed as described previously
(16).
RT-PCR. One microgram of ookinete total RNA was reverse transcribed with
Superscript II (Life Technologies) in the presence of d(T25) according to the
manufacturer’s instructions and then diluted to 100 ml with Tris-glycine buffer
(pH 8.0). One microliter was subjected to PCR amplification. The PbCHT1-
specific primers CHT1-PF (GCCAAGGAGCTAGCGGG) and CHT1-PR (CG
ATACCAGGTGCCCG) were used to amplify the PbCHT1 probe used in South-
ern and Northern blotting and for semiquantitative reverse transcription (RT)-
PCR. Gene Pbs25-specific primers were described previously (9). Degenerate
primers CHT2-Forward [GGTAT(A/T/C)AT(A/T/C)(G/C)(G/C)IGGITA(C/T)
TA(C/T)(G/C)(G/C)ITCITGG] (where I is inosine) and CHT2-Reverse
[GG(C/T)TCI(C/T)A(A/G)TCIA(C/T)(A/G)TCIA(C/T)CC(A/G)TC] were used
to amplify Plasmodium chitinase genes.
In vitro chitinase activity assay. Ten million ookinetes were homogenized in
phosphate-buffered saline (PBS) (pH 7.5) containing 1% Nonidet P-40 (Sigma)
and centrifuged at 20,000 3 g for 2 min; the supernatant was loaded into 1%
agarose gels in PBS containing 0.01% ethylene glycol chitin (Seikagaku). After
overnight incubation at 37°C, the gels were stained for 5 min in PBS containing
0.01% Fluorescent Brightener 28 (Sigma) and destained in distilled water. Chitin
hydrolysis was visualized under UV light. Relative intensities of hydrolysis were
measured by pixel density scanning with NIH Image software. Serratia marc-
escens chitinase A (SmChiA; 10 mU; Sigma) was used as a positive control for
allosamidin activity.
Nucleotide sequence accession number. Sequence data have been submitted to
the DDBJ/EMBL/GenBank databases under accession number AJ305256.
RESULTS
Identification and sequence analysis of PbCHT1. A partial
cDNA corresponding to PbCHT1 was obtained by differential
screening of a subtracted P. berghei cDNA library enriched for
ookinete-specific sequences (4). Subsequently, the remainder
of the PbCHT1 sequence was obtained by rapid amplification
of cDNA ends. PbCHT1 is encoded by a single large open
reading frame of 1,947 nucleotides encoding a 649-amino-acid
protein with a calculated Mr of 72,127. It contains a predicted
amino-terminal signal peptide of 18 amino acids resulting in a
mature protein with an Mr of 70,072. Homology searches re-
vealed high levels of sequence homology with the other Plas-
modium chitinases, PgCHT1 and PfCHT1. Amino acid se-
quence identity of PbCHT1 is substantially higher with
PgCHT1 (58%) than with PfCHT1 (19%), although the dif-
ferences at sequence similarity levels are less pronounced (81
and 76%, respectively).
In other respects also, PbCHT1 is more similar to PgCHT1
than to PfCHT1 (Fig. 1A). First, it contains a putative carboxy-
terminal chitin-binding domain (residues 495 to 648; PbCHT1
numbering) very similar to that present in PgCHT1. This do-
main is absent in PfCHT1. Second, PbCHT1 contains a region
of low complexity and low sequence conservation between
residues 37 and 152; this region contains nine imperfect re-
peats of the amino acid sequence E(NG)NGNGA/V (one-
letter amino acid code, with parentheses enclosing acids not
always present and a shill between two acids indicating the
presence of one or the other acid). It is likely that this amino-
terminal region downstream of the signal peptide constitutes a
proenzyme domain like that described for PgCHT1 (15). Given
the overall structural features and sequence homologies, it is
clear that PbCHT1 and PgCHT1 are orthologs, whereas Pf-
CHT1 is a paralog.
A comparison of the three Plasmodium chitinases with
SmChiA, a closely related family 18 glycosylhydrolase for
which the crystal structure has been determined (8), reveals
extended sequence homology for all three parasite chitinases
with a/b barrel subdomain 2 and a 1 b subdomain 3 of
SmChiA (Fig. 1). Based on similarities with lysozyme, SmChiA
subdomain 2 contains two catalytic dyad residues that are jux-
taposed in the substrate-binding groove: glutamate 315 and
aspartate 391 (Fig. 1). These residues are conserved in the
Plasmodium chitinases, although aspartate 391 has been sub-
stituted with glutamate. b-Sheet subdomain 1 of SmChiA is
structurally related to the fibronectin III domain; in the para-
site chitinases this domain is absent. Notably, sequence homol-
FIG. 2. Differential expression of PbCHT1. Total RNA from asex-
ual blood-stage parasites (lane 1), gametocytes (lane 2), and in vitro-
cultured ookinetes (lane 3) was subjected to Northern blot analysis
using a probe corresponding to PbCHT1. RNA amounts were normal-
ized using large- and small-subunit rRNAs (ethidium bromide
stained), as shown at the bottom of the figure.
FIG. 1. Comparison of PbCHT1, PgCHT1, PfCHT1, and SmChiA, a bacterial family 18 chitinase from S. marcescens. (A) Multiple amino acid
alignment (Clustal W). Residue identities are indicated by shading (grey, 75%; black, 100%), and secondary structure features (coils represent
helices; arrows represent sheets) are shown below the sequences. The predicted catalytic dyad (SmChiA residues 315 and 391) is marked with red
dots. Plasmodium chitinases show a high structural conservation with subdomains 2 (blue) and 3 (green) of SmChiA. (B) Stereo-space-filled image
of the atomic structure of SmChiA showing subdomains 2 (blue) and 3 (green) and the catalytic dyad (red). These domains correspond to the areas
of strong conservation in Plasmodium chitinases and are similarly colored in panel A. The numbers refer to the three subdomains.
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ogy starts just downstream of the putative proenzyme se-
quences and extends to include the entire SmChiA subdomains
2 and 3. Thus, all Plasmodium chitinases contain a hydrolytic
domain equivalent to SmChiA subdomains 2 and 3, while Pb-
CHT1 and PgCHT1 contain additional amino- and carboxy-
terminal subdomains corresponding to the putative proenzyme
and chitin-binding domains, respectively.
Expression of PbCHT1. To determine the pattern of expres-
sion of PbCHT1, we carried out a Northern blot analysis of
RNA samples purified from asexual blood-stage parasites, ga-
metocytes, or in vitro-cultured ookinetes. This analysis identi-
fied an abundant mRNA of approximately 2.5 kb in the ooki-
nete sample, while no signal was obtained in either asexual
blood-stage parasites or gametocytes (Fig. 2A). These results
strongly indicate the expression of PbCHT1 in ookinetes,
which is also the case for the other Plasmodium chitinases (14,
15). In fact, PgCHT1 was recently shown to be transported via
micronemes to the electron-dense area of the apical complex
for extracellular secretion (7).
Targeted disruption of PbCHT1. To investigate the function
of PbCHT1, we generated transgenic PbCHT1-disrupted par-
asites by insertion of a modified Toxoplasma gondii dihydrofo-
late reductase-thymidylate synthase gene cassette (DHFR/TS)
(13, 16) that confers resistance to the antimalarial drug py-
rimethamine into the PbCHT1 gene by double homologous
recombination (Fig. 3A). The DHFR/TS cassette was inserted
between nucleotide positions 660 and 1960 of PbCHT1 (Fig.
3A), thereby removing 1.3 kb of the PbCHT1 central coding
sequence, including the sequences encoding the putative bind-
ing pocket and the catalytic site.
Subsequently, two independent clonal transgenic parasite
populations (termed PbCHT1-KO clones 33 and 37) were as-
sessed for their integrity by Southern blot analysis of SphI-
digested genomic DNA. A probe corresponding to nucleotide
positions 710 to 1840 of PbCHT1 (no internal SphI sites
present) gave rise to a single band in the parental (wild-type
[WT]) parasites but no bands in the PbCHT1-KO parasites
(Fig. 3B), demonstrating the successful removal of the PbCHT1
central sequence by the insertion of the DHFR/TS cassette.
Cross-hybridization with other putative chitinase genes was not
observed under the conditions used. Conversely, a probe cor-
responding to the DHFR/TS cassette (two SphI sites present)
gave rise to three DHFR/TS-specific bands in the PbCHT1-KO
parasites but no signal in the WT sample (Fig. 3B). Together,
these results confirmed correct integration of the DHFR/TS
cassette into the target gene.
FIG. 3. Targeted disruption of PbCHT1 and molecular analyses. (A) Schematic diagram of the targeting strategy. Indicated is the transfection
vector pPbCHT1-KO containing the T. gondii DHFR/TS gene cassette (white box), P. berghei DHFR flanking sequences (gray boxes), and
PbCHT1-specific sequences (hatched boxes). The double homologous recombination crossover sites (crossed lines), the integration sites (arrows
with nucleotide positions), the SphI restriction sites, and the probes used in Southern blot analysis (thick lines) are shown. gDNA, genomic DNA.
(B) Southern blot analysis of SphI-digested genomic DNA from WT and PbCHT1-KO parasites using probes corresponding to PbCHT1 (left
panel) and to the DHFR/TS cassette (right panel). (C) RT-PCR analysis of total RNA derived from ookinete-enriched midgut stages of WT (left
lanes) and PbCHT1-KO (right lanes) parasites. Amplicons corresponding to PbCHT1(;1,100 bp) and Pbs25 (;600 bp) are shown.
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PbCHT1-KO parasites developed gametocytes and formed
ookinetes in vivo and in vitro, in numbers similar to and indis-
tinguishable from those of WT parasites in Giemsa-stained
blood films (data not shown). To confirm that PbCHT1 expres-
sion was abolished in the transgenic parasites, total RNA was
extracted from in vitro-cultured ookinetes and subjected to
RT-PCR using PbCHT1-specific primers. In the WT para-
sites, a band of approximately 1,100 bp corresponding to
PbCHT1 was amplified, while no band was amplified in the
PbCHT1-KO parasites. In contrast, a 600-bp band correspond-
ing to the reference ookinete gene Pbs25 (9) was amplified in
both parasite samples (Fig. 3C). Clearly, the absence of Pb-
CHT1 mRNA is in full agreement with the genotype of the
PbCHT1-KO parasites (Fig. 3B) and supports the successful
knockout of PbCHT1 expression.
Are there other chitinases of P. berghei? We performed
several experiments to investigate whether P. berghei had any
additional chitinase genes. First, we performed Western blot-
ting with ookinete homogenates and antiserum raised against a
PgCHT1 active-site peptide. This antiserum detects at least
two distinct chitinases in P. gallinaceum and cross-reacts with
PfCHT1 (7, 15). Thus, it is likely that this antiserum would
cross-react with PbCHT1 and other chitinases of P. berghei.
However, only a single band with an approximate Mr of 70,000
was detected in the WT parasites; as expected, this band was
absent in the PbCHT1-KO parasites (Fig. 4A). Based on its
apparent size and its absence in the PbCHT1-KO parasites,
this 70-kDa band likely corresponds to PbCHT1 and confirms
that the transgenic parasites are PbCHT1 null mutants. Pro-
longed development of the blot revealed a weak band with an
approximate Mr of 60,000 in the WT sample (data not shown),
indicating the processing of PbCHT1 and possibly reflecting
the cleavage of the putative proenzyme domain. No other
proteins were recognized, arguing against the presence of ad-
ditional chitinases in P. berghei.
Second, we designed degenerate primers for amino acid
sequences conserved among the three Plasmodium chitinases
and performed RT-PCR with RNA purified from WT and
PbCHT1-KO ookinetes. While we were able to amplify a
PbCHT1-specific sequence from the WT parasites, no product
could be amplified from the PbCHT1-KO parasites (data not
shown), again arguing against the expression of other chitinase
genes in this stage of the life cycle.
Third, we performed an in vitro chitinase activity assay with
ookinete homogenates and glycol chitin-containing agarose. In
this assay, chitinase activity is demonstrated by a dark area
around the well containing the homogenate, resulting from
hydrolysis of the chitin substrate by the diffusing chitinase. An
approximately 80% reduction in activity was observed in the
PbCHT1-KO ookinetes (Fig. 4B), again confirming that the
PbCHT1-KO parasites are PbCHT1 null mutants. This resid-
ual chitinase activity corresponds to background activity, as it
was also observed in homogenates from similarly purified
blood-stage parasites. This chitinase activity likely is derived
from contaminating mouse leukocytes or serum proteins, as
has been reported for human leukocytes and serum (5). Thus,
the apparent absence of residual ookinete-derived chitinase
activity in the PbCHT1-KO sample, combined with the results
from the Western and RT-PCR analyses, indicates that Pb-
CHT1 is the sole chitinase gene expressed in P. berghei ooki-
netes.
Infectivity of PbCHT1-KO parasites to Anopheles stephensi
mosquitoes. To assess the effects of PbCHT1 disruption on
mosquito infection, PbCHT1-KO and WT parasites were fed
to A. stephensi mosquitoes and compared for their ability to
form oocysts, a measure of parasite infectivity. In seven exper-
iments, significant (P , 0.01) reductions in oocyst numbers of
between 30 and 90% were obtained with the PbCHT1-KO
parasites (Table 1). The two independent clonal populations of
transgenic parasites (clones 33 and 37) had very similar trans-
mission phenotypes, indicating that the reduction in infectivity
is unlikely to be a result of clonal phenotypic variation.
Surprisingly, we observed significant levels of reduction in
FIG. 4. Analysis of P. berghei WT and PbCHT1-KO ookinete ho-
mogenates for additional chitinase activity. (A) Western blot analysis
with PgCHT1 active-site antiserum. (B) In vitro chitinase activity assay
with glycol chitin-containing agarose. Also included is a homogenate
from similarly purified blood stages (BS).
TABLE 1. Effect of PbCHT1 knockout on P. berghei infectivity to
A. stephensi
Expt Type of feed(clone)a
Mean 6 SEM no. of oocysts (no. of
midguts dissected)b in mosquitoes infected
with:
% of WT
value
WT PbCHT1-KO
1 gct (33) 95.2 6 5.8 (99) 63.0 6 3.9c (150) 66
2 gct (37) 96.0 6 6.3 (125) 68.2 6 4.0c (147) 71
3 gct (33) 54.9 6 4.5 (130) 28.2 6 2.5c (133) 51
4 gct (37) 49.6 6 3.0 (142) 25.1 6 2.2c (150) 50
5 ook (33) 49.2 6 2.4 (107) 14.1 6 0.9c (109) 29
6 ook (33) 33.8 6 1.7 (137) 7.3 6 0.6c (115) 22
7 ook (33) 2.41 6 0.2 (90) 0.34 6 0.06c (85) 14
a gct, gametocyte; ook, ookinete.
b Each experiment included pooled data from three mice (gct) and three
membrane feeders (ook).
c Significantly different (P , 0.01) from the value for the WT-infected control
group, as calculated by Student’s t test.
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the infectivity of the PbCHT1-KO parasites in both gametocyte
and ookinete feeds (Table 1). In A. stephensi, PM formation is
first detectable by electron microscopy at 12 h and continues
up to 48 h after blood feeding (1). In ookinete feeds, we
observed ookinetes in the midgut epithelium as early as 3 h
postfeeding, and by 12 h the majority had reached the midgut
epithelium (data not shown). Thus, in ookinete feeds most
ookinetes invade the midgut epithelium in the absence of a
developed PM. In contrast, in gametocyte feeds 20 to 30 h is
required for ookinete development in the midgut lumen (11);
consequently, the majority of ookinetes invade the midgut ep-
ithelium in the presence of a developed PM. Clearly, if
PbCHT1 played a role in PM disruption, then we would an-
ticipate infection levels more comparable to those of the WT
parasites in ookinete feeds. As this was clearly not the case, the
results suggest that the PM is not a target of PbCHT1 activity
in A. stephensi.
PbCHT1-KO oocysts formed normal numbers of sporozo-
ites, which were infectious to mice upon mosquito bite. More-
over, parasites from sporozoite-induced infections retained
their phenotype in subsequent mosquito transmissions (data
not shown). This result demonstrates that PbCHT1 functions
predominantly in the ookinete stage, an observation consistent
with its expression profile (Fig. 2). Indeed, chitinase activity is
unlikely to be required for downstream sporozoite invasion of
the salivary gland ducts of A. stephensi, as these have been
reported not to contain chitin (17).
Allosamidin does not inhibit PbCHT1. When we assessed
the effects of the chitinase inhibitor allosamidin on P. berghei
infectivity in A. stephensi, we found no decrease in oocyst
numbers (data not shown). Interestingly, we used an allosami-
din concentration (0.1 mM) that effectively abolished oocyst
development of P. falciparum and P. gallinaceum in A. freeborni
and A. aegypti, respectively (10). This result suggested that
allosamidin does not inhibit PbCHT1. To test this suggestion,
we added allosamidin to ookinete homogenates at concentra-
tions of up to 1 mM in our in vitro chitinase activity assay and
observed no inhibition of chitinase activity (Fig. 5A), while a
control chitinase activity (SmChiA) was inhibited (data not
shown). The concentration of 1 mM is far in excess (200-fold)
of that found to reduce P. gallinaceum chitinase activity in vitro
by more than 90% (10). The addition of allosamidin to blood
feeds did, however, have a clear effect on the ability of the
mosquitoes to digest the blood meal. At an allosamidin con-
centration of 0.1 mM, PMs and partially digested blood meals
were still present at 9 days postinfection in one-third of the
mosquitoes examined, while none of the control mosquitoes
contained blood meal remnants (Fig. 5B). A similar observa-
tion was made for A. freeborni and A. aegypti mosquitoes fed
allosamidin (10) and is indicative of the allosamidin inhibition
of mosquito-derived chitinase(s).
DISCUSSION
In this paper, we describe and characterize PbCHT1, the first
chitinase gene isolated from a rodent malaria species. We show
that the gene product, PbCHT1, contains putative proenzyme
and chitin-binding domains and is orthologous to a previously
described endochitinase, PgCHT1, from P. gallinaceum. Tar-
geted disruption of the PbCHT1 gene by double homologous
recombination has allowed us to study the existence of other
putative chitinase activities in P. berghei ookinetes as well as
the role of PbCHT1 in mosquito infection in the absence and
presence of a PM.
Our findings indicate that P. berghei ookinetes have a single
chitinase activity because (i) no additional bands were recog-
nized in Western blottings by a PgCHT1 active-site antibody,
(ii) no specific products could be amplified from PbCHT1-KO
ookinetes with Plasmodium chitinase gene-specific degenerate
primers, and (iii) most importantly, no residual ookinete-de-
rived chitinase activity was observed in PbCHT1-KO parasites
(Fig. 4). In fact, the same may be true for P. falciparum because
only a single chitinase gene has thus far been described in the
Malaria Genome Project databases, which now contain about
95% of the genome. Intuitively, if this assumption is correct
and P. gallinaceum does indeed possess both types of chitinase
genes, then it can be suggested that both P. falciparum and P.
berghei share an avian Plasmodium ancestor and that each has
retained a different one of the two chitinases.
Transmission experiments with A. stephensi have shown that
PbCHT1 null mutants are significantly impaired in oocyst for-
mation but that PbCHT1 is not essential for mosquito infec-
tion. The residual infectivity of the PbCHT1-KO ookinetes
may, at least to some extent, be the result of mouse-derived
chitinase activity; however, it is just as conceivable that A.
stephensi midgut chitin simply does not provide a foolproof
barrier for P. berghei infection. It should be noted that A.
stephensi is highly susceptible to P. berghei. In contrast, P.
falciparum infection of its anopheline vectors gives substan-
tially lower oocyst numbers, which could have implications for
the role of PfCHT1 in mosquito infection.
Reductions in infectivity were observed both in the presence
of a PM (gametocyte feeds) and in its absence (ookinete
feeds). Although in the absence of complementation we can-
not rule out the possibility that the reduced infectivity is the
FIG. 5. Effects of allosamidin. (A) In vitro chitinase activity assay
with P. berghei WT ookinete homogenates in the presence of 0, 0.1, and
1 mM allosamidin. (B) Effect of allosamidin on blood meal digestion.
Shown are dissected guts of mosquitoes at 9 days after blood feeding
in the presence (1) or absence (2) of 0.1 mM allosamidin.
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result of pleiotropic effects, the findings suggests that PbCHT1
plays a role other than PM disruption. We cannot rule out the
possibilities that chitin is present in the microvillus-associated
network or the epithelial cells themselves and that chitinase
activity is required to allow ookinete egress from these tissues.
In this respect, it should be noted that chitin precursors are
synthesized by epithelial cells and must traverse the microvil-
lus-associated network to form the mature PM. Experiments
are in progress to investigate these hypotheses.
Our data appear to conflict with previous chitinase inhibitor
studies conducted with P. gallinaceum and P. falciparum in A.
aegypti and A. freeborni mosquitoes, respectively, which did not
indicate a role for Plasmodium chitinases downstream of PM
disruption (10). In those experiments, however, transmission in
the absence of a PM was achieved not by conducting ookinete
feeds but instead by adding exogenous Streptomyces griseus
chitinase to the blood meal, thereby preventing PM formation.
Clearly, it is conceivable that the S. griseus chitinase may also
have affected potential chitin integrity in other midgut tissues.
Moreover, there may be substantial differences in chitin com-
position or deposition between these mosquito species and A.
stephensi. Thus, we cannot truly compare those experiments
with ours.
Allosamidin is a chitin-like metabolite that inhibits numer-
ous chitinase enzymes with different efficacies by binding to the
active site (12). Although it is known that allosamidin does not
universally inhibit chitinase enzymes (for example, S. griseus
chitinase is not inhibited [10]), it was surprising to discover that
PbCHT1, the ortholog of the efficiently inhibited PgCHT1, was
insensitive in our assay (Fig. 5A). It is known that single amino
acid replacements can alter substrate specificity and enable
catalytic turnover of compounds that previously strongly inhib-
ited enzyme activity (2). Modeling the homologous Plasmo-
dium chitinases on the atomic structure of the related bacterial
chitinase SmChiA (Fig. 1) highlights a number of candidate
residue replacements that may elicit such an effect. Notable
among these is a unique Lys366Pro replacement, which occurs
adjacent to the predicted catalytic Glu367 residue in PbCHT1.
This substitution would significantly alter the orientation of the
catalytic residue in the active site, which could change the
specificity for allosamidin; future site-directed mutagenesis
studies are needed to verify this hypothesis. In any event, these
findings may have implications for the long-term use of allosa-
midin or compounds like it as malaria transmission-blocking
drugs. The natural allelic variation of P. falciparum chitinase
enzymes is unknown, and under selective pressure by allosa-
midin, alleles containing enabling mutations could rise to a
high frequency in human malaria. Moreover, simple mutations
that render the enzymes insensitive to the inhibitor could arise
and be selected for.
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ADDENDUM IN PROOF
As this paper was going to press, a highly conserved se-
quence orthologous to PbCHT1 appeared in the P. yoelii da-
tabase accessible through The Institute for Genomic Research
website (www.tigr.org). This sequencing program is carried on
in collaboration with the Naval Medical Research Center and
is supported by the U.S. Department of Defense. At this time,
no other chitinase genes in this genome have been identified.
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